Zim Laboratories Ltd Performance
Day's Low
Day's High
₹120.1₹126.9552 Week's Low
52 Week's High
₹89.5₹131.4
| Returns % | |
| 1 Month Return | + 16.45 % |
| 3 Month Return | + 2.67 % |
| 1 Year Return | + 9.33 % |
| Market Stats | |
| Previous Close | ₹124.09 |
| Open | ₹124.10 |
| Volume | 5.23L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹604.64Cr |
Zim Laboratories Ltd Key Statistics
| P/E Ratio | 37.49 |
| PEG Ratio | -89.26 |
| Market Cap | ₹604.64 Cr |
| P/B Ratio | 2.01 |
| EPS | 3.54 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 7.87 |
Zim Laboratories Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹604.64 Cr | 11.06% | 0.66 | ₹17 Cr | ₹367 Cr | |
| BUY | ₹8,805.97 Cr | 4.56% | 0.50 | ₹135 Cr | ₹498 Cr | |
| NA | ₹156.91 Cr | -2.6% | 0.64 | ₹9 Cr | ₹131 Cr | |
| NA | ₹671.30 Cr | 440.91% | 0.54 | ₹23 Cr | ₹164 Cr | |
| NA | ₹319.85 Cr | 168.38% | 1.27 | NA | NA |
About Zim Laboratories Ltd
Share Price: ₹122.25 per share as on 05 Dec, 2024 04:01 PM
Market Capitalisation: ₹604.64Cr as of today
Revenue: ₹92.14Cr as on September 2024 (Q3 24)
Net Profit: ₹2.38Cr as on September 2024 (Q3 24)
Listing date: 25 Nov, 2022
Chairperson Name: Anwar S Daud
| Organisation | Zim Laboratories Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Zim Laboratories Ltd
Zim Laboratories Reports Decrease in Revenue and Net Income - 12 Jun, 2024
Zim Laboratories reported a 7.8% decrease in revenue, with net income down by 29% and profit margin decreasing from 6.1% to 4.7% in FY 2024. EPS also decreased from ₹5.02 to ₹3.54. The Outside India segment contributed 78% of total revenue. Zim Laboratories shares are up 7.0% from a week ago.ZIM Laboratories' Accrual Ratio Indicates Lower Free Cash Flow - 21 May, 2024
An article suggests that ZIM Laboratories' free cash flow was significantly lower than its statutory profit, with a negative free cash flow of ₹576m over the last year. The company's earnings per share have grown impressively in the last three years, but investors are advised to analyze risks and warnings before investing.ZIM Lab Reports Increase in Net Sales and Quarterly Net Profit - 17 May, 2024
ZIM Lab's standalone net sales for March 2024 increased by 12.39% YoY, with a quarterly net profit of Rs. 7.89 crore, up 10.51% from the previous year. The company's EPS has also increased to Rs. 1.62 in March 2024. However, ZIM Lab shares have given negative returns of -5.65% over the last six months.
Insights on Zim Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 0.9 Cr → 2.38 Cr (in ₹), with an average increase of 62.2% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, ZIMLAB stock has moved up by 12.9%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 82.82 Cr → 93.46 Cr (in ₹), with an average increase of 11.4% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 33.26% of holdings in Sep 2024 quarter
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 66.63% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 144.2% return, outperforming this stock by 130.6%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 67.2% return, outperforming this stock by 57.9%
Zim Laboratories Ltd Financials
Zim Laboratories Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 33.26% | 0.00 | |
| Foreign Institutions | 0% | 33.33 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 66.63% | 0.01 | |
| Others | 0.1% |
Zim Laboratories Ltd Key Indicators
Zim Laboratories Ltd Valuation
Zim Laboratories Ltd in the last 5 years
Lowest (6.12x)
June 11, 2018
Today (37.49x)
December 4, 2024
Industry (57.42x)
December 4, 2024
Highest (198.80x)
July 1, 2021
Zim Laboratories Ltd Earnings and Dividends
Zim Laboratories Ltd Earnings Results
Zim Laboratories Ltd’s net profit fell -42.65% since last year same period to ₹2.38Cr in the Q2 2024-2025. On a quarterly growth basis, Zim Laboratories Ltd has generated 164.44% jump in its net profits since last 3-months.
Read More about Earnings ResultsZim Laboratories Ltd Dividends May,2019
In the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.23%.
Read More about Dividends
Zim Laboratories Ltd Technicals Summary
Bearish
Neutral
Bullish
Zim Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Zim Laboratories Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Zim Laboratories Ltd shares.
Zim Laboratories Ltd (ZIMLAB) share price today is ₹122.25
Zim Laboratories Ltd is listed on NSE
Zim Laboratories Ltd is listed on BSE
- Today’s highest price of Zim Laboratories Ltd is ₹126.95.
- Today’s lowest price of Zim Laboratories Ltd is ₹120.1.
PE Ratio of Zim Laboratories Ltd is 37.49
PE ratio = Zim Laboratories Ltd Market price per share / Zim Laboratories Ltd Earnings per share
Today’s traded volume of Zim Laboratories Ltd(ZIMLAB) is 5.23L.
Today’s market capitalisation of Zim Laboratories Ltd(ZIMLAB) is ₹604.64Cr.
| Zim Laboratories Ltd(ZIMLAB | Price |
|---|---|
52 Week High | ₹131.4 |
52 Week Low | ₹89.5 |
Zim Laboratories Ltd(ZIMLAB) share price is ₹122.25. It is down -6.96% from its 52 Week High price of ₹131.4
Zim Laboratories Ltd(ZIMLAB) share price is ₹122.25. It is up 36.59% from its 52 Week Low price of ₹89.5
| Zim Laboratories Ltd(ZIMLAB | Returns |
|---|---|
1 Day Returns | -1.84% |
1 Month Returns | 16.45% |
3 Month Returns | 2.67% |
1 Year Returns | 9.33% |